Until now, in situ tumor immunology has been acknowledged as highly significant for the prognosis of multiple cancers, even if most of the research in the field of esophageal cancer has focused on ESCC, and marginal attention has been paid to the EAC [ 8 , 9 ].
← all excerpts
Definition of a Multi-Omics Signature for Esophageal Adenocarcinoma Prognosis Prediction.
1
—
—